13907-88-5 Usage
Nitroso compound
A chemical compound containing a -NO group 1-nitroso-3-phenylimidazolidin-2-one is a nitroso compound, which means it has a -NO group in its structure.
Commonly used as a reagent
Utilized in various synthetic reactions in organic chemistry This compound is frequently used as a reagent in organic chemistry due to its ability to participate in different synthetic reactions.
Nitrosating agent
Ability to transfer a nitroso group to other compounds 1-nitroso-3-phenylimidazolidin-2-one can act as a nitrosating agent, transferring its nitroso group to other molecules in chemical reactions.
Used in preparation of pharmaceuticals
Involved in the synthesis of various drugs This chemical compound is used in the preparation of pharmaceuticals, contributing to the development of different drugs.
Application in dyes and other organic compounds
Contributes to the production of dyes and other organic molecules 1-nitroso-3-phenylimidazolidin-2-one is also employed in the synthesis of dyes and other organic compounds.
Potential biological and pharmacological properties
Possesses possible biological and pharmacological activities This compound has been studied for its potential biological and pharmacological properties, making it a subject of interest in research.
Potential as an anti-tumor agent
Capable of inhibiting or preventing tumor growth One of the potential properties of 1-nitroso-3-phenylimidazolidin-2-one is its ability to act as an anti-tumor agent, which could be useful in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 13907-88-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,0 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13907-88:
(7*1)+(6*3)+(5*9)+(4*0)+(3*7)+(2*8)+(1*8)=115
115 % 10 = 5
So 13907-88-5 is a valid CAS Registry Number.
13907-88-5Relevant articles and documents
INHIBITORS OF MALT1 PROTEASE
-
Page/Page column 91, (2014/06/24)
The present invention relates to compounds which are inhibitors of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALTl) and to their use in therapy, in particular in the treatment or prevention of a disease or disorder which is treatable by an inhibitor of a paracaspase. The present invention also relates to pharmaceutical compositions containing such compounds.